Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 13, 2019

SELL
$63.59 - $78.71 $5,087 - $6,296
-80 Closed
0 $0
Q1 2019

May 09, 2019

BUY
$50.75 - $80.54 $4,060 - $6,443
80 New
80 $6,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.63B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Bremer Bank National Association Portfolio

Follow Bremer Bank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bremer Bank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Bremer Bank National Association with notifications on news.